Skip to Main Content

News Center

FDA

CTM, FDA Collaborate to Assess Extrapolation of Anti-Epileptic Drugs’ Effectiveness

March 24, 2016

FDA praises the Center’s efforts to bring academic, government, and industry stakeholders together for collaborative project with wide-reaching implications.

School of Pharmacy Sees Unparalleled Growth in Research Funding

December 7, 2015

New grants and contracts from a multitude of non-profit and government organizations, as well as the private sector, help the School of Pharmacy achieve the highest funding increase among all professional and graduate schools at the University of Maryland, Baltimore.

CERSI Symposium Highlights Use of Biomarkers in Drug Development

August 28, 2015

More than 500 researchers from academia, government, and industry gather to gain perspective on biomarker development and the application of biomarkers in preclinical and clinical research.

SOP’s Polli Testifies for GDUFA Renewal at National Public Meeting

August 6, 2015

Testimony examined the impact of FDA-supported research in generic drugs and advocated for continued funding through renewal of the Generic Drug User Fee Amendments of 2012 (GDUFA).

SOP Faculty Receive $1.5 Million from the FDA to Study Iron Medications

February 24, 2015

Interdisciplinary group will research the effectiveness of brand versus generic iron medications used to treat anemia in kidney disease patients

FDA Awards Two Grants, $1.2 Million to Center for Translational Medicine

January 12, 2015

Grants will support the development of quantitative pharmacometric models to advance the evaluation of generic drugs.

CERSI-Sponsored Conference Brings “Big Data” Experts to UMB

February 25, 2014

Researchers from academia, government, and industry discuss how increasingly large, complex datasets can be harnessed to improve the drug development process.